New to Meducation?
Sign up
Already signed up? Log In

Category

11
0
25

In which cancers is radiotherapy considered more useful than chemotherapy etc?

I can't work out any good way of understanding which cancers are best treated with what. When are cancers: Well treated with radiotherapy? Well treated with chemotherapy? Well treated with both? Thanks in advance!  
Jess Pobbs
about 7 years ago
12
1
20

PCUTT1 2007 | Chemotherapy for Hormone-Refractory, Metastatic Disease

ProstateCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank.” Chemotherapy for Hormone-Refractory, Metastatic Disease. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 9 years ago
4
1
4

BCU Think Tank 2 | 06 - Section 4

Cardiac Toxicity Associated with Anthracycline-Based Chemotherapy (Nonanthracycline Alternatives)  
Dr Neil Love
over 9 years ago
9
1
0

BCU Think Tank 1 | 07 - Adjuvant Chemotherapy

www.BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank”  
Dr Neil Love
over 9 years ago
13
1
11

BCUTT2 2007 | Adjuvant Chemotherapy

BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank.” Adjuvant Chemotherapy. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 9 years ago
6
1
22

SABCS 2008 | Case05

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 62-year-old woman with a neglected 6-cm, ER/PR-positive, HER2-positive IDC and biopsy-proven lung metastases who refuses chemotherapy. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 9 years ago
5
1
15

What's with the new guidelines for antibiotic prophylaxis?

I was going to talk to Dr. Quinn, but Dr. Yagiela has such a nice chair in his office that I just went into his office instead. He answers some of my questions about the new guidelines for antibiotic prophylaxis. It turns out that we might not actually be saving anyone by doing it  
Carl Jones
over 9 years ago
6
1
14

First Line Chemo for Advanced NSCLC (Video)

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the evolution of our current standards for chemotherapy for the first line treatment of metastatic non-small cell lung cancer.  
Howard (Jack) West, MD
over 9 years ago
5
1
17

First Line Chemo for Advanced NSCLC (Audio)

This presentation by medical oncologist and lung cancer expert Dr. Jack West describes the evolution of our current standards for chemotherapy for the first line treatment of metastatic non-small cell lung cancer.  
Howard (Jack) West, MD
over 9 years ago
2
1
11

Janessa Laskin Interview (Audio)

This interview by medical oncologist Dr. Jack West of fellow medical oncologist and lung cancer expert Dr. Janessa Laskin covers the current standards and controversial aspects of post-operative chemotherapy for resected early stage NSCLC.  
Howard (Jack) West, MD
over 9 years ago
1
1
13

Janessa Laskin Interview (Video)

This interview by medical oncologist Dr. Jack West of fellow medical oncologist and lung cancer expert Dr. Janessa Laskin covers the current standards and controversial aspects of post-operative chemotherapy for resected early stage NSCLC.  
Howard (Jack) West, MD
over 9 years ago
0
1
13

Antiangiogenesis in First Line NSCLC (Video)

This presentation by medical oncologist and lung cancer expert Dr. Jack West introduces the concept of angiogenesis, with a focus on the combination of Avastin (bevacizumab) with chemotherapy for advanced non-small cell lung cancer (NSCLC).  
Howard (Jack) West, MD
over 9 years ago
13
1
19

Antiangiogenesis in First Line NSCLC (Audio)

This presentation by medical oncologist and lung cancer expert Dr. Jack West introduces the concept of angiogenesis, with a focus on the combination of Avastin (bevacizumab) with chemotherapy for advanced non-small cell lung cancer (NSCLC).  
Howard (Jack) West, MD
over 9 years ago
8
1
5

Optimal Treatment of Unresectable Locally Advanced NSCLC (Video)

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the evolution of our current standards for chemotherapy for the first line treatment of metastatic non-small cell lung cancer.  
Howard (Jack) West, MD
over 9 years ago
7
1
4

Optimal Treatment of Unresectable Locally Advanced NSCLC (Audio)

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the evolution of our current standards for chemotherapy for the first line treatment of metastatic non-small cell lung cancer.  
Howard (Jack) West, MD
over 9 years ago
0
1
12

Chemotherapy for Second Line Treatment of Non-Small Cell Lung Cancer (NSCLC) (Video)

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the development of current standards and anticipated benefits vs. risks of second line chemotherapy for advanced non-small cell lung cancer (NSCLC).  
Howard (Jack) West, MD
over 9 years ago
13
1
26

Chemotherapy for Second Line Treatment of Non-Small Cell Lung Cancer (NSCLC) (Audio)

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the development of current standards and anticipated benefits vs. risks of second line chemotherapy for advanced non-small cell lung cancer (NSCLC).  
Howard (Jack) West, MD
over 9 years ago
8
1
9

Timing of Maintenance/Second Line Chemotherapy in Advanced NSCLC (Video)

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the emerging data about the controversial aspects of timing the transition from first line to second line chemotherapy for advanced non-small cell lung cancer (NSCLC).  
Howard (Jack) West, MD
over 9 years ago
7
1
14

Timing of Maintenance/Second Line Chemotherapy in Advanced NSCLC (Audio)

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the emerging data about the controversial aspects of timing the transition from first line to second line chemotherapy for advanced non-small cell lung cancer (NSCLC).  
Howard (Jack) West, MD
over 9 years ago
0
1
25

Ramalingam on Advanced NSCLC: First Line and Maintenance Therapy (Audio)

This interview by medical oncologist Dr. Jack West of Dr. Suresh Ramalingam, medical oncologist at Emory University in Atlanta, covers the evolving first line treatment standards of chemotherapy and targeted therapy for the first line treatment, as well as the emerging issue of maintenance therapy after initial treatment of advanced NSCLC.  
Howard (Jack) West, MD
over 9 years ago